BioSystem Development

By Adam Bonislawski
Agilent Technologies and Integrated Diagnostics said this week that they have entered a strategic partnership to develop mass spec workflows for protein biomarker diagnostics.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Agilent Technologies today said that it has completed the acquisition of BioSystem Development for an undisclosed sum.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Agilent Technologies today announced two deals that are expected to grow its footprint in the life science space.

The firm, which makes the AssayMap platform, plans to use the funds to scale up its manufacturing capabilities, increase the speed to market of its new products, and support expansion of its product pipeline.

Agilent will integrate mass-tagged PCR primers with LC-MS to enable the rapid identification of food-borne pathogens in one deal with UC-Davis, and combine its automated liquid handling platform with BioSystem's AssayMap high-throughput micro-chromatography technology in another collaboration.

The firms are combining their respective technologies to provide a platform that they said could process hundreds of samples in three hours or less.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.